# clm_BA7FB06172CD

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 17,983,700,000 United States dollar  
valid_from: 2014-06-30  
valid_to: 2014-09-30  
published: 2014-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_570B41055A07  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 17,983,700,000 United States dollar", as of 2014-06-30 (until 2014-09-30). Claim clm_BA7FB06172CD, https://asof.is/claim/clm_BA7FB06172CD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947814000129/0000059478-14-000129-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947814000129/0000059478-14-000129-index.htm (primary, SEC EDGAR 10-Q Q2 FY2014, published 2014-07-28)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 18,338,100,000 United States dollar | valid 2014-03-31 to 2014-06-30 | conf 0.95 | superseded | superseded_by [clm_BA7FB06172CD](/claim/clm_BA7FB06172CD.md) | [clm_06455B93E953](/claim/clm_06455B93E953.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
